Iron chelators for acute stroke

Review identified two eligible RCTs (n=333) and found no benefit for the use of iron chelators in spontaneous intracerebral haemorrhage; the added value of iron‐chelating therapy in people with ischaemic stroke or subarachnoid haemorrhage remains unknown.

Source:

Cochrane Database of Systematic Reviews